Abiomed Impella Recall Issued For Heart Pump Catheter’s Instructions Due to Blood Clot Risks
The third Impella heart pump recall in as many months warns that they lack instructions for doctors on the risks of blood clots linked to the devices.
The third Impella heart pump recall in as many months warns that they lack instructions for doctors on the risks of blood clots linked to the devices.
The FDA warns about 8,000 Abiomed Impella blood pumps may suffer motor damage when placed too close to TAVR valves, leading to an increased risk of severe injury and death.
Nearly 500 Impella 5.5 heart pumps by Abiomed have been recalled following reports of fluid leaks, pump failures and patient injuries.
The FDA has released clinical trial data on Abiomed Impella RP Heart Pump Systems, declaring the device safe, but updated its warning label to recommend it only be used on…
The FDA warns that the Abiomed Impella RP System has a higher rate of mortality among patients than its initial clinical trials predicted, potentially because the manufacturer did not take…
A Class 1 medical device recall has been issued for Abiomed, Inc.’s AB5000 Circulatory Support System after it was determined that the device, which keeps the heart pumping in cases…